Reasoned therapeutic protocol in outpatients with COVID-19
Seventy percent of patients affected by SARS-COV-2 disease are asymptomatic or with symptoms that not required Hospitalization. The aim of the study was to reduce the impact of the virus by reducing its ability to attack cells and the inflammatory burden and the prothrombotic effects.
No detection of SARS-CoV-2 from urine, expressed prostatic secretions, and semen in 74 recovered COVID-19 male patients: A perspective and urogenital evaluation
The coronavirus disease 2019 (COVID-19) has been spreading all over the world since December 2019. SARS-CoV-2 RNA was undetectable in the urogenital secretions, and semen quality declined slightly, while hormonal profiles remained normal.
Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review
Altering the intestinal microbiota has been proposed as a treatment for inflammatory bowel diseases (IBDs) There are no established associations between specific microbes and IBD.
Preoperative biliary drainage using a fully covered self-expandable metallic stent for pancreatic head cancer: A prospective feasibility study
Preoperative biliary drainage using a fully covered self-expandable metallic stent for pancreatic head cancer: A prospective feasibility study
The effectiveness of Lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multicentre trial
Constipation is one of the most common problems among children, with a prevalence ranging from 7 to 30%. It is treated with defecation training and laxative medications.
Self-sizing radiofrequency ablation balloon for eradication of Barrett's esophagus: results of an international multicenter randomized trial comparing 3 different treatment regimens
The 360 Express has replaced the traditional system for circumferential radiofrequency ablation (RFA) of Barrett's esophagus (BE) The aim was to compare 3 different ablation regimens for the 360 Express.
MicroRNA-21 as a diagnostic marker for hepatocellular carcinoma: A systematic review and meta-analysis
MicroRNA-21 is one of the oncogenic miRNAs which may be a potential diagnostic biomarker for hepatocellular carcinoma (HCC) A total of 515 HCC patients, and 338 healthy or chronic hepatitis controls from six published studies were enrolled in this meta-analysis.
Optimal bowel cleansing for colonoscopy: split the dose! A series of meta-analyses of controlled studies
Authors: Colonoscopy is considered the criterion standard for detecting colorectal cancer. They aim to assess the efficacy of split-dose versus non-split-dose preparations and the rate of adequate preparation according to type and dose of laxatives.